|1.||Tokuda, Harukuni: 28 articles (04/2015 - 02/2002)|
|2.||Akihisa, Toshihiro: 15 articles (04/2015 - 03/2004)|
|3.||Nishino, Hoyoku: 11 articles (06/2007 - 02/2002)|
|4.||Suzuki, Nobutaka: 9 articles (10/2013 - 04/2010)|
|5.||Tokuda, H: 9 articles (12/2001 - 07/2000)|
|6.||Yasukawa, Ken: 8 articles (04/2015 - 11/2002)|
|7.||Pan, Min-Hsiung: 8 articles (02/2014 - 11/2006)|
|8.||Ho, Chi-Tang: 8 articles (02/2014 - 11/2006)|
|9.||Kimura, Yumiko: 8 articles (06/2012 - 10/2005)|
|10.||Suzuki, Takashi: 8 articles (02/2012 - 03/2004)|
01/01/1992 - "The application of EGCG before challenge with 7,12-dimethylbenz[a]anthracene as tumor initiator resulted in significant reduction both in percentage of mice with tumors and number of tumors per mouse compared with a non-EGCG-pretreated group of animals. "
04/01/2013 - "The aim of this study was to determine the cytotoxicity of Ant-4,4, a homospermidine-anthracene conjugate, and assess the long-term effects by determining whether cancer cells were able to recover from treatment. "
07/01/2008 - "To assess the relative roles of Atm, Arf, and p53 in the suppression of Ras-driven tumors, we examined susceptibility to skin carcinogenesis in 7,12-dimethylbenz(a)anthracene/12-O-tetradecanoylphorbol-13-acetate (TPA)-treated Atm- and p53-deficient mice and compared these results to previous studies on Arf-deficient mice. "
06/23/2006 - "In vivo studies indicated that C3G treatment decreased the number of non-malignant and malignant skin tumors per mouse induced by 12-O-tetradecanolyphorbol-13-acetate (TPA) in 7,12-dimethylbenz[a]anthracene-initiated mouse skin. "
01/01/2004 - "Many toxicology studies on AQ used contaminated anthracene-derived AQ-OX, including a National Toxicology Program (NTP) 2-year cancer bioassay that reported a weak to modest increase in tumors in the kidney and bladder of male and female F344/N rats and in the livers of male and female B6C3F1 mice. "
|2.||Breast Neoplasms (Breast Cancer)
12/05/2008 - "HL-37, a novel anthracene derivative, induces Ca(2+)-mediated apoptosis in human breast cancer cells."
07/01/2008 - "Induction of breast cancer was achieved by using the 7,12-dimethylbenz(a) anthracene. "
07/01/2006 - "Female Sprague Dawley rats at 55 days of age were treated with dimethylbenz(a)anthracene to induce breast cancer. "
11/01/2005 - "To identify high-frequency, low-penetrance breast cancer modifier genes, we have developed a rat genetic model that uses the Wistar-Kyoto (WKy) inbred strain, resistant to developing 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis, as a congenic donor and the susceptible Wistar-Furth (WF) strain as the recipient. "
08/01/2002 - "Histopathologic characterization of mammary neoplastic lesions induced with 7,12 dimethylbenz(alpha)anthracene in the rat: a comparative analysis with human breast tumors."
01/01/1992 - "This study was designed to evaluate the point mutations in the murine c-Ha-ras gene of skin papillomas induced by initiation with dibenz[a,j]anthracene (DB[a,j]A), its bay-region anti-diol epoxide ((+/-)anti-DB[a,j]A-DE), and a 7,14-dimethyl analogue (7,14-diMeDB[a,j]A). "
01/01/2012 - "Further, its efficacy was evaluated against di-methyl benzo anthracene-induced skin papilloma in Swiss albino mice. "
04/01/2010 - "STAT2 deficiency also inhibited 7,12-dimethylbenz(a)anthracene/12-O-tetradecanoylphorbol-13-acetate-induced skin carcinogenesis as indicated by reduced papilloma multiplicity. "
02/01/2005 - "In addition, IH-901 given prior to each topical dose of TPA markedly lowered the number of papillomas in mouse skin induced by 7,12-dimethylbenz[a]anthracene. "
12/01/2001 - "Because 7,12-dimethylbenz[a]anthracene induces an activating mutation of H-ras, this provides one possible explanation for suppression of papilloma formation when FAK protein is limiting."
01/01/1984 - "Parallel tumour induction studies showed that TPA increased markedly the incidence of tracheal carcinomas following initiation with a low dose of 7,12-dimethylbenz[a]anthracene. "
05/01/2014 - "Tongue carcinoma was induced in purebred New Zealand white rabbits by exposure to 7,12-dimethylbenz[α]anthracene and mechanical stimulation. "
01/01/2010 - "Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene."
05/01/2006 - "[Effects of mobile-phone microwave on dimethylbenz (a) anthracene induced mammary carcinoma development in rats]."
01/01/2006 - "Effects of neonatally-administered 17beta-estradiol on induction of mammary carcinomas by 7, 12-dimethylbenz[a]anthracene in female rats."
|5.||Skin Neoplasms (Skin Cancer)
04/01/2009 - ""Swiss albino mice" were divided into five groups depending on the combination of skin cancer-inducing 7,12-dimethylbenz[a]anthracene and garlic treatments. "
06/01/2000 - "To test if NF1 can play a part in skin tumor formation, we analyzed effects of the skin cancer initiator dimethylbenz-anthracene and/or the tumor promoter 12-O-tetradecanoyl-13-acetylphorbol on mice heterozygous for null mutations in Nf1 (Nf1+/-). "
09/01/2011 - "The present study evaluated the efficacy of a hydrodynamics-based IFN-γ gene transfection for skin cancer treatment, in which the plasmid DNA encoding IFN-γ was administered into the tail vein of mice following 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate-induced skin carcinogenesis. "
08/01/2014 - "The results of in vivo studies against dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mice skin carcinogenesis demonstrated that the IL/o ME could effectively treat skin cancer in 4 weeks. "
08/01/2014 - "Skin cancer in mice was initiated by single topical application of 7,12-dimethylbenz[a]anthracene (DMBA) and promoted by repeated TPA application for 20 weeks. "
|4.||DNA (Deoxyribonucleic Acid)
|5.||Sodium Selenite (Selenite)
|6.||Guanosine Triphosphate (GTP)
|4.||Drug Therapy (Chemotherapy)